Health Care & Life Sciences » Pharmaceuticals | ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
11,105.00
169,037.00
154,684.00
27,365.00
31,144.00
43,008
Total Accounts Receivable
12,513.00
17,297.00
21,932.00
45,895.00
58,788.00
64,842
Inventories
3,518.00
7,518.00
13,387.00
26,183.00
37,727.00
40,503
Other Current Assets
580.00
9,626.00
2,580.00
3,264.00
3,746.00
4,124
Total Current Assets
27,716.00
203,478.00
192,583.00
102,707.00
131,405.00
152,477
Net Property, Plant & Equipment
4,537.00
5,223.00
7,131.00
10,998.00
20,403.00
38,090
Total Investments and Advances
-
-
-
5,002.00
5,006.00
5,021
Intangible Assets
12,247.00
43,905.00
68,235.00
177,630.00
231,628.00
205,184
Other Assets
-
3,307.00
-
300.00
1,029.00
1,868
Total Assets
44,500.00
263,709.00
285,265.00
322,864.00
412,138.00
430,604
ST Debt & Current Portion LT Debt
-
-
-
-
3,353.00
Accounts Payable
1,429.00
2,654.00
2,066.00
3,389.00
3,630.00
Income Tax Payable
-
4,253.00
-
2,398.00
-
Other Current Liabilities
2,109.00
6,326.00
9,690.00
26,161.00
32,245.00
Total Current Liabilities
3,538.00
13,233.00
11,756.00
31,948.00
39,228.00
Long-Term Debt
-
110,691.00
113,427.00
120,643.00
198,154.00
Deferred Taxes
-
7,796.00
17,316.00
26,227.00
22,667.00
Other Liabilities
-
-
-
625.00
-
Total Liabilities
3,538.00
123,924.00
125,183.00
153,216.00
237,382.00
Common Equity (Total)
40,962.00
139,785.00
160,082.00
169,648.00
174,756.00
Total Shareholders' Equity
40,962.00
139,785.00
160,082.00
169,648.00
174,756.00
Total Equity
40,962.00
139,785.00
160,082.00
169,648.00
174,756.00
Liabilities & Shareholders' Equity
44,500.00
263,709.00
285,265.00
322,864.00
412,138.00

About ANI Pharmaceuticals

View Profile
Address
210 Main Street West
Baudette Minnesota 56623
United States
Employees -
Website http://www.anipharmaceuticals.com
Updated 07/08/2019
ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.